Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,901–9,920 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

Ketamine HCl Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ephedrine Sulfate Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCl Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methadone HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Labetalol HCl in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Potassium Chloride in 5% Dextrose in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Adenosine Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Succinylcholine Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ketamine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Potassium Chloride in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine HCl in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Morphine Sulfate in 5% Dextrose in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Morphine Sulfate in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCl in 5% Dextrose in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone HCl Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason
Lack of sterility assurance.
Recall initiated
December 27, 2017
Reported by FDA
February 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.